introduction to pharma

Reviews
Shared by: BANDA DUDS
Categories
Tags
Stats
views:
440
rating:
not rated
reviews:
0
posted:
12/5/2008
language:
English
pages:
0
Introduction to Pharmacology Pharmacology  the study of science of drugs Drug  any chemical that affects the processes of a living organism I. Drug sources: a. b. c. d. II. Drug uses: plants animals minerals chemical synthesis/ biogenetic engineering  prevent diseases  treat diseases  diagnose diseases  prevent pregnancy  maintain health III. Drug names  Chemical name o the drug’s chemical composition and molecular structure o ex.( +/- ) – 2 – ( p-isobutylphenyl ) proponic acid  Generic Name ( Nonproprietary name ) o name given by the United States Adopted Name Council o universally accepted o ex.ibuprofen  Trade Name ( Brand name/ Proprietary name) o the drug has a registered trademark ; use of the name restricted by the drug’s owner o ex. Motrin IV. Drug Standards:  same drug name must have same strength, quality & purity  based on United States Pharmacopeia and National Formulary (USP-NF) V. Drug references:  American Hospital Formulary Service (AHFS) Drug Information  Physicians’ Desk Reference (PDR)  Package inserts  Drug Facts and Comparisons  Saunders/ Lipincott’s Nursing Drug Guide  Journals  Internet VI. Phases of Drug Development 1. Preclinical trial 2. Phase 1 3. Phase 2 4. Phase 3 5. Phase 4 VII. Legal Regulation A. Food and Drug Administration (FDA) Pregnancy Categories: Category A Category B Category C Category D Category X  no risk to fetus  no risk in animal fetus; no human studies available  adverse effects to animal fetus; no human studies available  possible fetal risk in humans reported  fetal abnormalities reported; + evidence of fetal risk in animal/& human studies. B. Controlled Substances:  controlled substances  OTC drugs  prescription drugs  orphan drugs  dependence Drug Enforcement Agency (DEA) Schedules of Controlled Substances: Schedule I Drugs  high potential for abuse  used for research only  ex. heroin, marijuana, lysergic acid diethylamide (LSD) Schedule II Drugs  high abuse potential  severe physical & psychologic dependence  acceptable medical use, with restrictions  ex. amphetamines, cocaine, mepiridine (Demerol) , morphine, anabolic steroids Schedule III Drugs  moderate potential for abuse  psychological dependence , low physical dependence  acceptable medical use, by prescription only  ex. secobarbital (Seconal), Tylenol with codeine Schedule IV  low potential for abuse  limited physical & psychological dependence  ex. diazepam (Valium), phenobarbital, chlordiazepoxide (Librium) Schedule V  low potential for abuse  acceptable medical use  OTC narcotic drugs, sold only by registered pharmacists: buyer must be 18yo  Ex. cough syrups with codeine eg. Guaifenesin, diphenoxylate HCL with atropine ( Lomotil) Pharmacologic Principles I. Drug Action:  Pharmaceutics  Pharmacokinetics  Pharmacodynamics II. Drug Effect:  Pharmacotherapeutics Pharmaceutics  the study of how various drug forms influence pharmacokinetic and pharmacodynamic activities. o disintegration o dissolution Pharmacokinetics  the study of what the body does to the drug: o Absorption o Distribution o Metabolism or biotransformation o Excretion or elimination Pharmacodynamics  the study of what the drug does to the body : o the mechanism of drug action in living tissues. Pharmacotherapeutics  the use of drugs and the clinical indications for drugs to prevent and treat diseases. Pharmacognosy  the study of natural ( plant and animal ) drug sources. I. The 3 Phases of Drug Action: A. Pharmaceutic Phase 1. disintegration 2. dissolution  Rate limiting – time it takes for drug to disintegrate & dissolve to be absorbed by the body B. Pharmacokinetic Phase 1. Absorption:  passage of a drug into the bloodstream from site of administration  Processes of drug absorption:  passive absorption  active absorption  pinocytosis  Drug absorption of Oral Preparations: Liquids, elixirs, syrups Fastest Suspension solutions Powders Capsules Tablets Coated tablets Enteric-coated tablets Slowest  The rate at which the drug leaves its site of administration, and the extent to which absorption occurs.  Bioavailability  Factors that affect absorption :  solubility of drug  food or fluids administered with the drug  dosage formulation  status of the absorptive surface  rate of blood flow to the small intestine  acidity of the stomach  status of GI motility  administration route of drug  Routes :  a drug’s route of administration affects the rate and extent of absorption of the drug. o Enteral o Parenteral o Topical  Enteral Route  drug is absorbed into the systemic circulation through the oral or gastric mucosa, the small intestine, or rectum. o oral o sublingual* o buccal o rectal  Parenteral Route  Intravenous *  Intramuscular  Subcutaneous  Intradermal  Intrathecal  Intraarticular  Topical Route  skin ( including transdermal patches )  eyes, ears & nose  lungs ( inhalation )*  vagina First – Pass Effect  the metabolism of a drug and its passage from the liver into the circulation.  A drug given via the oral route may be extensively metabolized by the liver before reaching the systemic circulation ( high first – pass effect ).  The same drug – given IV – bypasses the liver, preventing the first – pass effect from taking place, the more drug reaches the circulation.  Routes that bypass the liver : o sublingual o buccal o rectal* o intravenous o intranasal transdermal vaginal intramuscular subcutaneous inhalation 2. Distribution  transport of a drug by the bloodstream to its site of action  Factors affecting drug distribution:  protein-binding  water soluble vs fat soluble  areas of rapid distribution o heart, liver, kidneys, brain  areas of slow distribution o muscle, skin, fat 3. Metabolism or biotransformation  the transformation of a drug into an inactive metabolite, a more soluble compound or a more potent metabolite  liver*  others: kidneys, lungs, plasma ,intestinal mucosa  Factors that decrease metabolism:  cardiovascular problem  renal problem  starvation  liver problem  erythromycin or ketoconazole drug therapy  Factors that increase metabolism:  nicotine  alcohol  barbiturates & glucocorticoids  rifampin therapy  Half-life o time it takes for one half of the original amount of a drug in the body to be removed. o a measure the rate at which drugs are removed from the body 4. Excretion  elimination of drugs from the body  kidneys*  others: lungs, exocrine glands (sweat, salivary or mammary glands), skin & intestinal tract C. Pharmacodynamics Phase  Onset of Action  time it takes for the drug to elicit a therapeutic response  minimum effective concentration (MEC)  Peak Action  time it takes for drug to reach its maximum therapeutic response  Duration of Action  the time a drug concentration is sufficient to produce its therapeutic response  Receptor Theory  most receptors are found on cell membrane  drug binding occurs on receptors  lock & key interaction :  Agonist & antagonist:  Agonists  drugs that attracts to receptors  stimulate/ enhance a response  ex. Insulin, isoproterenol – stimulate beta 1 receptor  Antagonists  drugs that attracts to receptors  block a response  ex. cimetidine – blocks H2 receptor  Nonspecific & Nonselective Drugs  Nonspecific Drugs  affect various sites of the body  ex. Bethanecol  stim. cholinergic receptor  strengthen bladder contraction,increases HR, decreases BP, bronchiole & pupil constriction  Nonselective Drugs  affect various receptors  ex. Epinephrine  acts on alpha1, beta 1 & 2 receptors  Categories of drug action: a. depress cellular activities b. stimulates cellular activities c. inhibit or kill organisms d. act as substitute for missing chemicals  Therapeutic Index & therapeutic Range:  Therapeutic Index (TI)  relationship bw the drug’s therapeutic effects & its adverse effects TI= LD50 ED50   High TI  wide margin of safety Low TI  narrow margin of safety  Therapeutic Range (therapeutic window)  drug concentration bw therapeutic effect & toxic effect  Ex. Digoxin = 0.5 to 2 ng/ml  Peak & Trough Level  Peak drug level  highest plasma concentration of drug at a specific time  indicate rate of absorption  Trough level  lowest plasma concentration  indicate rate of elimination  Loading dose  large initial dose given for immediate response.  given to achieve a rapid minimum effective concentration.  Ex. Digoxin (digitalization) II. Pharmacotherapeutics  use of drugs to treat disease. A. Types of Therapies: 1. acute therapy  px is critically ill & requires immediate intensive therapy 2. empiric therapy  based on practical experience rather than on pure scientific data 3. maintenance therapy  chronic conditions that don’t resolve 4. supplemental or replacement therapy  replenish or substitute missing substances in the body 5. supportive therapy  doesn’t treat the cause of disease but maintains other threatened body systems until the patient’s condition resolve. 6. palliative therapy  used for end-stage or terminal diseases to make the patient as comfortable as possible Drug Effects:  Main effect  desired therapeutic effect  reason drug is administered  Side effects  physiologic effects that are not related to desired drug effects  expected, well-known reactions that result in little or no change in patient intervention  Adverse Reactions  more severe than side effects  undesirable & unexpected effects occurring even at normal dose  Local vs Systemic drug effect  Placebo Effect  a therapeutic effect that results from a patient’s belief in the benefits of a medication  Factors affecting Drug Effects:  Age  Size  Sex  Genetic factors  Disease conditions  Emotional conditions  Route of administration  Time of day  Drug taking history  Environmental conditions  Drug-interactions Drug Interactions Drug interactions  occur bw drugs or bw drugs & foods I. Drug – Drug Interactions: 1. additive drug effect 2 drugs produce equivalent effects when either drug is given alone in higher doses. ex. diuretic & beta blocker aspirin & codeine 2. synergistic/potentiation – 2 drugs produce same effects but one drug enhances the effect of the other drug  greater effect ex. meperidine (Demerol) & promethazine alcohol & sedatives 3. antagonistic – combined effects of 2 drugs are less than the effect produced by the 2 individual drugs ex. tetracycline & antacid morphine & naloxone 4. Incompatibility – 2 drugs mixed together  chemically incompatible ex. ampicillin & gentamicin II. Drug – Food Interactions:  tetracycline & dairy products  levodopa & high protein meals  monoamine oxidase inhibitor (MAO) inhibitor & tyramine-rich foods  nitrofurantoin  Metoprolol & food  lovastatin Adverse Drug Reactions I. Dose- related adverse reactions:  Secondary effects  Hypersensitivity or hypersusceptibility  Overdose  Iatrogenic  Tolerance  Dependence Patient sensitivity-related adverse reactions  Allergic reaction  Idiosyncrasy I. Dose-related adverse reactions: a. Secondary effects ex. morphine antihistamine b. Hypersensitivity or hypersusceptibility  excessive therapeutic response even with usual therapeutic dose ex. anticholinergics  dry mouth, blurring of vision, urinary retention & constipation narcotic analgesic oral contraceptives digitalis aspirin c. Overdose & toxicity  excessive dose  exaggerated response  pediatric & elderly ex. CNS depressants digoxin d. Iatrogenic effects  adverse reactions that caused by drugs that are part of medical tx.  drug-induced diseases ex. antineoplastics, aspirin, corticosteroids  GI irritation & bleeding propanolol gentamicin e. tolerance  decrease response to drug over time ex. psychoactive drugs (e.g. benzodiazepines) propanolol cocaine morphine II. f. dependence  strong physical & psychological need for a certain drug  habituation  addiction g. cumulation  body cannot metabolize & excrete one dose of a drug completely before the next dose. II. Patient sensitivity-related adverse reactions:  result from unusual & extreme sensitivity to a drug a. Allergic reaction  abnormal response due to antibodies against a certain drug ex. antibiotics (penicillin) , aspirin, sulfonamides Types: 1. Immediate allergic reaction :  Urticaria sxs:  skin rash with severe itching  swelling  Anaphylaxis sxs:  dyspnea  extreme weakness  nausea & vomiting  cyanosis  hypotension  circulatory collapse 2. Delayed allergic reaction  Serum sickness Sxs.  itchy rash  fever  swollen & stiff joints Interventions:  notify prescriber & discontinue drugs  emergency tx for anaphylactic shock  Epinephrine  Antihistamines or topical corticosteroids  Cool environment b. Idiosyncratic reactions:  unique or strange responses to certain drugs thought to be caused by genetic factors ex. succinylcholine primaquine III. Other drug- related effects: a. Teratogenic  produce organ defects in developing fetus ex. marijuana/ cocaine alcohol aminoglycoside b. Carcinogenic  induce malignant changes in cells ex. estrogen therapy antineoplastics for pediatric leukemias c. Mutagenic  produce genetic mutations IV. Drug-induced tissue & organ damage: A. Dermatological reactions: Sxs:  hives/ urticaria  rash  exfoliative dermatitis  Stevens- Johnson syndrome Ex. procainamide - butterfly- rash sulfonamide - Stevens-Johnson syndrome Tx:  frequent skin care  notify prescriber & discontinue drug  topical corticosteroids, antihistamine & emollients B. Stomatitis S/sxs:  swollen gums & tongue.  difficulty swallowing  bad breath  pain in mouth & throat ex. antineoplastic agents (eg fluorouracil) Tx:  frequent mouth care  frequent, small meals D. Gingival hyperplasia S/sxs:  red, & enlarged gums ex. phenytoin (anticonvulsant) E. Superinfections S/sxs:  fever  diarrhea  hairy tongue  mucous membrane lesions  vaginal discharge ex. antibiotics F. Blood dyscrasias  agranulocytosis*  anemia  thrombocytopenia s/sxs:  fever & chills  extreme weakness  sore throat  high risk to infection  high risk for bleeding/hemorrhage ex. antineoplastics & antipsychotics antibiotics (eg. chloramphenicol, sulfonamides) anti-inflammatory (eg non-steroidal anti-inflammatory drugs (NSAID) tx.  monitor blood counts  protect from exposure to infection  avoid activities that result in injury or bleeding G. Hepatotoxicity s/sxs:  jaundice*  fever  nausea & vomiting  increase in liver enzymes (AST & ALT)  altered bilirubin ex. isoniazid (INH) acetaminophen H. Nephrotoxicity s/sxs  edema  increase Crea & BUN  decrease hematocrit  electrolyte imbalances ex. aminoglycosides (eg gentamicin) sulfonamide I. Ototoxicity s/sxs  dzziness  ringing in ears  loss of balance  hearing problem ex. aminoglycoside (eg. Gentamicin) azithromycin, erythromycin aspirin quinidine J. Ocular toxicity s/sxs  burring of vision  color vision changes  blindness ex. chloroquine (anti-malarial ) K. Hypoglycemia s/sxs  headache  tremors  drowsiness  cold clammy skin  seizures/coma ex. antidiabetic agents (eg. Insulin, glipizide) L. Hyperglycemia s/sxs  polyphagia  polyuria  polydipsia  kussmaul’s respiration  fruity breath ex. ephedrine ( bronchodilator) M. Hypokalemia s/sxs  serum K  irregular, weak pulse  weakness & numbness of extremities  paralytic ileus o absent bowel sounds o abdominal distention ex. loop diuretics (eg, furosemide) N. Hyperkalemia s/sxs  same as hypokalemia ex. potassium-sparing diuretics (eg. Spironolactone) antineoplastic drugs O. General CNS effects s/sx  anxiety  insomnia  nightmares ex. beta-blockers (eg. Metoprolol) P. Atropine- like (Cholinergic) effects s/sxs  dry mouth  constipation  urinary retention  decrease sweating,  hot dry skin ex. antidepressants (eg. TCA) Q. Extrapyramidal reactions/ parkinson- like syndrome s/sxs  immobility (akinesia)  rigidity  muscular tremors  violent movement of head & arms (dystonia)  restlessness (akathisia) ex. antipsychotic drugs R. Neuroleptic Malignant syndrome s/sxs  extrapyramidal symptoms  hyperthermia ex. general anesthetics S. Photosensitivity s/sxs  itching  scaling  reddening of skin Ex. sulfonamides, tetracycline T. Cough - ACE inhibitors U. Gray Baby Syndrome - chloramphenicol V. Osteoporosis – corticosteroids, heparin W. Pseudomembranous colitis – clindamycin X. Discolors teeth – tetracycline Y. Nasal stuffiness – reserpine Z. cervical cancer – estrogen hemorrhage – oral anticoagulants, heparin The capacity to laugh at things, including ourselves at times, means that we are still the masters of our fate…

Related docs
Bal Pharma Ltd
Views: 160  |  Downloads: 1
THE PHARMA EXECUTIVE MINI-MBA
Views: 55  |  Downloads: 1
pharma research institutes in india
Views: 72  |  Downloads: 11
Pest Analysis of pharma Industry-COMPLETE PROJECT
Views: 356  |  Downloads: 32
MGI PHARMA 2006 Annual Report
Views: 294  |  Downloads: 15
Pharma_Professional_March_2007
Views: 28  |  Downloads: 0
WiCON Launches Pharma China News Service
Views: 0  |  Downloads: 0
premium docs
Other docs by BANDA DUDS
Drugs for Parkinson_27s 2
Views: 107  |  Downloads: 3
Pharmaceutical Calculations
Views: 205  |  Downloads: 13
Pain Medications
Views: 78  |  Downloads: 8
Miscell- Gout
Views: 53  |  Downloads: 2
Lipid Lowering Drugs
Views: 29  |  Downloads: 7
Laxatives
Views: 26  |  Downloads: 4
Effects of Adrenergics figure
Views: 36  |  Downloads: 6
Drugs for HF and Angina
Views: 180  |  Downloads: 6
Drugs for HF and Angina
Views: 327  |  Downloads: 6
Drugs for Coagulation Disorders
Views: 80  |  Downloads: 5
Drugs for Anemia
Views: 259  |  Downloads: 11
Drug Calculations
Views: 120  |  Downloads: 2
Diuretics
Views: 122  |  Downloads: 9
CV Agents - Revised
Views: 465  |  Downloads: 8
CORONARY HEART DISEASE
Views: 29  |  Downloads: 2